A minisymposium featuring a keynote lecture by Prof. Tadashi Watabe titled “From Astatine to Emerging Targets: Clinical Translation of Theranostics in Osaka” will be held at Oslo Cancer Cluster Innovation park as a part of the joint OUH/UiO RLT- and theranostics initiative coordinated by Caroline Stokke.
A mini-symposium featuring a keynote lecture by Prof. Tadashi Watabe titled “From Astatine to Emerging Targets: Clinical Translation of Theranostics in Osaka” will be held at Oslo Cancer Cluster Innovation Park on June 19th. The event is open for all, registration here.
This is a follow up of the successful symposium Clinical Infrastructure & Trial Opportunities in the Norwegian Radiopharma & Theranostics Ecosystem, that was part of a meeting series in the Oslo Science City RLT- and theranostics initiative coordinated by Caroline Stokke.
Prof. Frederik Giesel, Chairman of the Nuclear Medicine Department at the University Hospital Dusseldorf, will also visit the same dates, and will give a lecture on PSMA and FAP on June 17th at 14:00 at Oslo Cancer Cluster Innovation Park (Jonas Einarsson Auditorium), close to the Radium hospital. The lecture is open to all, please notify Caroline Stokke of attendance.